Patient successfully completed a wear trial with the nalu spinal cord stimulator system on (b)(6) 2023 and had a permanent system implanted on (b)(6) 2023 to replace an existing competitor system.The nalu system was the third system to be implanted for this patient to treat the same area of pain and was implanted in the same anatomical location as the previous systems.Patient had the nalu system activated approximately two weeks after implant, during a post-op clinic visit, and reported receiving stimulation and pain therapy at that time.On (b)(6) 2023 the patient contacted a local nalu clinical specialist to report discomfort at the incision site and a "jolting sensation" that occurred occasionally regardless of the nalu system being on or off.Patient also reported discontent with having any kind of implanted stimulator and being able to palpate the implanted anchors.Patient reported refusal to wear or use the nalu system after the initial activation and requested explant.System explant was performed on (b)(6) 2023 with no reported complications.
|
The nalu system was the third implantable neuromodulation system used by this patient, with all three systems being from different manufacturers.Patient reported receiving therapy upon initial activation, however, was displeased with being able to palpate the system under the skin and expressed not wanting to have anything implanted.It is unlikely that the patient complaint of a "jolting sensation" was related to the nalu system as the patient stated this occurred even with the system turned off.The explanted device was retained by the medical facility and is unavailable for investigation by nalu to verify no malfunction.Physician reported that this case is likely psychosomatic in nature and unrelated to the actual device or it's components.
|